Subjective Outcomes After ACL Reconstruction With BQT Autograft

May 20, 2021 updated by: Jesper Glerup, Region Zealand

The purpose of the study is to compare short-term patient reported outcome measures (PROM) of Bone-Quadriceps-Tendon (BQT) autograft with Semitendinosus-Gracilis (STG) and Bone-Patellar-Tendon-Bone (BPTB) autografts following Anterior Cruciate Ligament Reconstruction (ACLR).

The PROM used are Knee Injury and Osteoarthrithis Outcome Score (KOOS) and Tegner. Difference in change in KOOS, KOOS subscales and Tegner from preoperative baseline to one-year follow-up and absolute KOOS, KOOS subscales and Tegner at one-year follow-up were evaluated. All of which were BQT compared to STG and BPTB, respectively. The primary outcome is change in KOOS from preoperative baselinge to one-year follow-up. Other outcomes are secondary.

The hypothesis was that patients receiving the BQT autograft show similar results in KOOS, KOOS subscales and Tegner as patients receiving STG or BPTB autografts.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

30000

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients from the nationwide Danish Knee Ligament Reconstruction Register (DKLR) recruited from both private and public clinics from January 1st 2005 through December 31st 2018.

Description

Inclusion Criteria:

-

Exclusion Criteria:

  • Revision ACL Surgery
  • Multiligament surgery
  • Nonresponders in PROM at preoperative baseline or one-year follow-up

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
BQT
Patients treated with the Bone Quadriceps Tendon (BQT) autograft
The choice of graft at primary ACL Reconstruction
STG
Patients treated with the Semitendinosus-Gracilis (STG) autograft
The choice of graft at primary ACL Reconstruction
BPTB
Patients treated with the Bone-Patellar Tendon-Bone (BPTB) autograft
The choice of graft at primary ACL Reconstruction

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Knee Injury and Osteoarthritis Outcome Score from preoperative baseline to one-year follow-up
Time Frame: 1 year
BQT compared to STG and BPTB, respectively
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Knee Injury and Osteoarthritis Outcome Score subscale Pain from preoperative baseline to one-year follow-up
Time Frame: 1 year
BQT compared to STG and BPTB, respectively
1 year
Change in Knee Injury and Osteoarthritis Outcome Score subscale Symptoms from preoperative baseline to one-year follow-up
Time Frame: 1 year
BQT compared to STG and BPTB, respectively
1 year
Change in Knee Injury and Osteoarthritis Outcome Score subscale Activities of Daily Living (ADL) from preoperative baseline to one-year follow-up
Time Frame: 1 year
BQT compared to STG and BPTB, respectively
1 year
Change in Knee Injury and Osteoarthritis Outcome Score subscale Sports/Recreation from preoperative baseline to one-year follow-up
Time Frame: 1 year
BQT compared to STG and BPTB, respectively
1 year
Change in Knee Injury and Osteoarthritis Outcome Score subscale Quality of Life (QoL) from preoperative baseline to one-year follow-up
Time Frame: 1 year
BQT compared to STG and BPTB, respectively
1 year
Change in Tegner activity score from preoperative baseline to one-year follow-up
Time Frame: 1 year
BQT compared to STG and BPTB, respectively
1 year
Absolute results of Knee Injury and Osteoarthritis Outcome Score subscale Pain at one-year follow-up
Time Frame: 1 year
BQT compared to STG and BPTB, respectively
1 year
Absolute results of Knee Injury and Osteoarthritis Outcome Score subscale Symptoms at one-year follow-up
Time Frame: 1 year
BQT compared to STG and BPTB, respectively
1 year
Absolute results of Knee Injury and Osteoarthritis Outcome Score subscale Activities of Daily Living (ADL) at one-year follow-up
Time Frame: 1 year
BQT compared to STG and BPTB, respectively
1 year
Absolute results of Knee Injury and Osteoarthritis Outcome Score subscale Sports/Recreation at one-year follow-up
Time Frame: 1 year
BQT compared to STG and BPTB, respectively
1 year
Absolute results of Knee Injury and Osteoarthritis Outcome Score subscale Quality of Life (QoL) at one-year follow-up
Time Frame: 1 year
BQT compared to STG and BPTB, respectively
1 year
Absolute results of Tegner activity score at one-year follow-up
Time Frame: 1 year
BQT compared to STG and BPTB, respectively
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2005

Primary Completion (ACTUAL)

December 31, 2018

Study Completion (ACTUAL)

December 31, 2018

Study Registration Dates

First Submitted

May 12, 2021

First Submitted That Met QC Criteria

May 20, 2021

First Posted (ACTUAL)

May 25, 2021

Study Record Updates

Last Update Posted (ACTUAL)

May 25, 2021

Last Update Submitted That Met QC Criteria

May 20, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • BQT-1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Injuries

Clinical Trials on Graft type at ACLR

3
Subscribe